| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -13.50M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CLYM returned +589.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +310.0% |
| 1 year | +589.1% |
| 5 years | -36.2% |
| All-time high | $25.69 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CLYM would be worth today ›No. Climb Bio, Inc. has not paid a dividend in the past 12 months.
Climb Bio, Inc. stock trades on NASDAQ under the ticker symbol CLYM.
Climb Bio, Inc. is part of the Healthcare sector.
Climb Bio, Inc. has a market cap of 941.95M USD, based on the latest quote.
